Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
6m agoProPetro Holding Corp. Prices Upsized $600 Million Convertible Senior Notes Offering
6m agoBunker Hill Mining on Track for June Restart of Operations
6m agoAnfield Energy Demonstrates the Economic Viability of its Hub-And-Spoke Uranium and Vanadium Production Strategy Via Its Updated Preliminary Economic Assessment
33m agoADP Announces Pricing of its Senior Notes Due 2036
33m agoADTRAN Holdings, Inc. reports first quarter 2026 financial results
Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc.

About

Aldeyra Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Feb 18 2026
Aldeyra Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Dec 16 2025
Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease
Nov 13 2025
Aldeyra Therapeutics Announces Expansion of RASP Platform to Include Central Nervous System Diseases and Provides Updates on Reproxalap at Research & Development Webcast
Nov 11 2025
Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
Nov 6 2025
Aldeyra Therapeutics to Host Research & Development Update Webcast Event Scheduled for Thursday, November 13 at 8:00 a.m. ET
Case study
How Aldeyra Therapeutics, Inc. runs its investor program on 6ix — audience, formats, and program overview.

Community Chat

Ask AI

6ix6ix